Health News

Latest articles in Health

FDA panel eases restrictions on peptides as lab-grown mini brains predict Alzheimer's drug response

An FDA advisory panel voted to ease restrictions on some peptides over agency scientists' objections. Separately, researchers at Sciencedaily reported that lab-grown mini brains grown from patients' cells can predict which Alzheimer's treatments will work. The organoids revealed striking differences in how Alzheimer's-related tissue responds to an antidepressant, opening the door to more personalized treatments.